C3糸球体症および原発性免疫複合体介在性膜性増殖性糸球体腎炎における代替エンドポイントに関するデルファイコンセンサス
Fernando Caravaca-Fontán1, Fadi Fakhouri2, Christoph Licht3
1Research Institute Hospital Universitario 12 de Octubre, Madrid, Spain.
Kidney international reports
|January 8, 2026
まとめ
タンパク尿症の減少は、これらのまれな腎疾患において腎機能を温存するためのC3GおよびIC-MPGNの主要な治療目標です。6か月でタンパク尿症が50%減少すると、意味のある治療上の利点が得られます。
さらに関連する動画
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
861
09:16Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
7.3K
関連する概念動画
Chronic Kidney Disease III: Interprofessional Care
333
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
185
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
185
